InvestorsHub Logo
Followers 21
Posts 1400
Boards Moderated 0
Alias Born 03/03/2021

Re: HyGro post# 519557

Wednesday, 10/05/2022 6:21:28 PM

Wednesday, October 05, 2022 6:21:28 PM

Post# of 688116
Optune is a device, not a biologic, so, much easier to gain approval.


NVCR completed their Phase 3 trial with no disruptions and gained approvals by numerous regulators. Let's see what happens with NWBO's dubious trial and an application if they can actually complete one.



Average time for new drug is 15 years. That is without Covid delay or new discovery of psuedoprogression. That got worked out over 2 years and here were are, right on time !!!

Endpoints changed well before data lock. AF acknowledges that .

NWBO took 16 YEARS to complete a clinical trial. Had a partial stop in the trial. Manipulated the protocol, comparator, endpoints and SAP after the close of the trial.
There is NOBODY that has managed a trial so poorly.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News